Annual Net Income
-$8.63 M
+$7.71 M+47.16%
December 31, 2023
Summary
- As of February 8, 2025, AMPE annual net profit is -$8.63 million, with the most recent change of +$7.71 million (+47.16%) on December 31, 2023.
- During the last 3 years, AMPE annual net income has risen by +$7.26 million (+45.69%).
- AMPE annual net income is now -125.40% below its all-time high of $33.99 million, reached on December 31, 2018.
Performance
AMPE Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$2.05 M
-$825.00 K-67.13%
December 31, 2023
Summary
- As of February 8, 2025, AMPE quarterly net profit is -$2.05 million, with the most recent change of -$825.00 thousand (-67.13%) on December 31, 2023.
- Over the past year, AMPE quarterly net income has increased by +$166.00 thousand (+7.48%).
- AMPE quarterly net income is now -109.32% below its all-time high of $22.04 million, reached on March 31, 2018.
Performance
AMPE Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$8.63 M
+$166.00 K+1.89%
December 31, 2023
Summary
- As of February 8, 2025, AMPE TTM net profit is -$8.63 million, with the most recent change of +$166.00 thousand (+1.89%) on December 31, 2023.
- Over the past year, AMPE TTM net income has increased by +$7.71 million (+47.16%).
- AMPE TTM net income is now -125.40% below its all-time high of $33.99 million, reached on December 31, 2018.
Performance
AMPE TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
AMPE Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +47.2% | +7.5% | +47.2% |
| 3 y3 years | +45.7% | +55.5% | +45.7% |
| 5 y5 years | -125.4% | -234.7% | +36.7% |
AMPE Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +49.5% | -67.1% | +68.0% | at high | +57.6% |
| 5 y | 5-year | at high | +49.5% | -101.4% | +68.0% | at high | +57.6% |
| alltime | all time | -125.4% | +83.4% | -109.3% | +95.2% | -125.4% | +83.4% |
Ampio Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$8.63 M(-47.2%) | -$2.05 M(+67.1%) | -$8.63 M(-1.9%) |
| Sep 2023 | - | -$1.23 M(-10.4%) | -$8.80 M(-37.1%) |
| Jun 2023 | - | -$1.37 M(-65.5%) | -$13.98 M(-4.8%) |
| Mar 2023 | - | -$3.98 M(+79.2%) | -$14.68 M(-10.1%) |
| Dec 2022 | -$16.34 M(-4.3%) | -$2.22 M(-65.4%) | -$16.34 M(-19.7%) |
| Sep 2022 | - | -$6.41 M(+209.7%) | -$20.34 M(+15.9%) |
| Jun 2022 | - | -$2.07 M(-63.3%) | -$17.56 M(-7.8%) |
| Mar 2022 | - | -$5.64 M(-9.4%) | -$19.04 M(+11.5%) |
| Dec 2021 | -$17.07 M(+7.4%) | -$6.22 M(+71.6%) | -$17.07 M(+10.4%) |
| Sep 2021 | - | -$3.63 M(+2.0%) | -$15.47 M(+1.7%) |
| Jun 2021 | - | -$3.56 M(-3.0%) | -$15.21 M(+5.7%) |
| Mar 2021 | - | -$3.67 M(-20.6%) | -$14.38 M(-9.5%) |
| Dec 2020 | -$15.89 M(+16.6%) | -$4.62 M(+37.1%) | -$15.89 M(+29.2%) |
| Sep 2020 | - | -$3.37 M(+23.3%) | -$12.30 M(-23.8%) |
| Jun 2020 | - | -$2.73 M(-47.3%) | -$16.15 M(+24.3%) |
| Mar 2020 | - | -$5.18 M(+407.7%) | -$13.00 M(-4.6%) |
| Dec 2019 | -$13.63 M(-140.1%) | -$1.02 M(-85.9%) | -$13.63 M(+23.0%) |
| Sep 2019 | - | -$7.22 M(-1814.7%) | -$11.08 M(-672.8%) |
| Jun 2019 | - | $421.00 K(-107.2%) | $1.94 M(-68.5%) |
| Mar 2019 | - | -$5.81 M(-481.1%) | $6.13 M(-81.9%) |
| Dec 2018 | $33.99 M(-165.5%) | $1.53 M(-73.7%) | $33.99 M(-418.7%) |
| Sep 2018 | - | $5.80 M(+25.6%) | -$10.67 M(-48.5%) |
| Jun 2018 | - | $4.62 M(-79.0%) | -$20.72 M(-25.9%) |
| Mar 2018 | - | $22.04 M(-151.1%) | -$27.95 M(-46.1%) |
| Dec 2017 | -$51.89 M(+170.8%) | -$43.13 M(+914.0%) | -$51.89 M(+328.1%) |
| Sep 2017 | - | -$4.25 M(+63.0%) | -$12.12 M(+2.2%) |
| Jun 2017 | - | -$2.61 M(+37.0%) | -$11.86 M(-17.1%) |
| Mar 2017 | - | -$1.90 M(-43.2%) | -$14.30 M(-25.4%) |
| Dec 2016 | -$19.16 M(-40.1%) | -$3.35 M(-16.0%) | -$19.16 M(-25.8%) |
| Sep 2016 | - | -$3.99 M(-21.0%) | -$25.81 M(-10.9%) |
| Jun 2016 | - | -$5.05 M(-25.3%) | -$28.98 M(-7.4%) |
| Mar 2016 | - | -$6.76 M(-32.4%) | -$31.28 M(-1.6%) |
| Dec 2015 | -$32.01 M | -$10.01 M(+39.8%) | -$31.80 M(+0.3%) |
| Sep 2015 | - | -$7.16 M(-2.7%) | -$31.71 M(-6.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2015 | - | -$7.36 M(+1.0%) | -$33.83 M(-3.8%) |
| Mar 2015 | - | -$7.28 M(-26.5%) | -$35.17 M(-7.8%) |
| Dec 2014 | -$38.13 M(+58.8%) | -$9.91 M(+6.8%) | -$38.13 M(+7.2%) |
| Sep 2014 | - | -$9.28 M(+6.8%) | -$35.55 M(+9.9%) |
| Jun 2014 | - | -$8.69 M(-15.1%) | -$32.35 M(+7.6%) |
| Mar 2014 | - | -$10.24 M(+39.5%) | -$30.07 M(+25.3%) |
| Dec 2013 | -$24.01 M(+107.1%) | -$7.34 M(+20.9%) | -$24.01 M(+18.0%) |
| Sep 2013 | - | -$6.07 M(-5.4%) | -$20.35 M(+20.7%) |
| Jun 2013 | - | -$6.42 M(+53.6%) | -$16.86 M(+30.3%) |
| Mar 2013 | - | -$4.18 M(+13.6%) | -$12.94 M(+11.6%) |
| Dec 2012 | -$11.59 M(-36.9%) | -$3.68 M(+42.3%) | -$11.59 M(-4.2%) |
| Sep 2012 | - | -$2.58 M(+3.5%) | -$12.10 M(+0.1%) |
| Jun 2012 | - | -$2.50 M(-12.0%) | -$12.09 M(-2.6%) |
| Mar 2012 | - | -$2.84 M(-32.3%) | -$12.42 M(-32.4%) |
| Dec 2011 | -$18.36 M(+128.0%) | -$4.19 M(+62.5%) | -$18.36 M(+7.0%) |
| Sep 2011 | - | -$2.58 M(-8.6%) | -$17.16 M(+0.8%) |
| Jun 2011 | - | -$2.82 M(-67.9%) | -$17.02 M(+10.9%) |
| Mar 2011 | - | -$8.78 M(+194.4%) | -$15.35 M(+90.6%) |
| Dec 2010 | -$8.05 M(+432.7%) | -$2.98 M(+22.0%) | -$8.05 M(+42.3%) |
| Sep 2010 | - | -$2.44 M(+113.1%) | -$5.66 M(+51.7%) |
| Jun 2010 | - | -$1.15 M(-22.6%) | -$3.73 M(+24.7%) |
| Mar 2010 | - | -$1.48 M(+151.2%) | -$2.99 M(+98.0%) |
| Dec 2009 | -$1.51 M(+4639.2%) | -$589.90 K(+14.7%) | -$1.51 M(+63.1%) |
| Sep 2009 | - | -$514.50 K(+26.3%) | -$926.90 K(+121.0%) |
| Jun 2009 | - | -$407.40 K(+8048.0%) | -$419.50 K(+1219.2%) |
| Dec 2008 | -$31.90 K(-0.3%) | -$5000.00(-29.6%) | -$31.80 K(-10.7%) |
| Sep 2008 | - | -$7100.00(+115.2%) | -$35.60 K(-1.4%) |
| Jun 2008 | - | -$3300.00(-79.9%) | -$36.10 K(-24.9%) |
| Mar 2008 | - | -$16.40 K(+86.4%) | -$48.10 K(+50.3%) |
| Dec 2007 | -$32.00 K(+3100.0%) | -$8800.00(+15.8%) | -$32.00 K(+36.2%) |
| Sep 2007 | - | -$7600.00(-50.3%) | -$23.50 K(+45.1%) |
| Jun 2007 | - | -$15.30 K(+5000.0%) | -$16.20 K(+1700.0%) |
| Mar 2007 | - | -$300.00(0.0%) | -$900.00(+50.0%) |
| Dec 2006 | -$1000.00 | -$300.00(0.0%) | -$600.00(+100.0%) |
| Sep 2006 | - | -$300.00 | -$300.00 |
FAQ
- What is Ampio Pharmaceuticals annual net profit?
- What is the all time high annual net income for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals annual net income year-on-year change?
- What is Ampio Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals quarterly net income year-on-year change?
- What is Ampio Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals TTM net income year-on-year change?
What is Ampio Pharmaceuticals annual net profit?
The current annual net income of AMPE is -$8.63 M
What is the all time high annual net income for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high annual net profit is $33.99 M
What is Ampio Pharmaceuticals annual net income year-on-year change?
Over the past year, AMPE annual net profit has changed by +$7.71 M (+47.16%)
What is Ampio Pharmaceuticals quarterly net profit?
The current quarterly net income of AMPE is -$2.05 M
What is the all time high quarterly net income for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high quarterly net profit is $22.04 M
What is Ampio Pharmaceuticals quarterly net income year-on-year change?
Over the past year, AMPE quarterly net profit has changed by +$166.00 K (+7.48%)
What is Ampio Pharmaceuticals TTM net profit?
The current TTM net income of AMPE is -$8.63 M
What is the all time high TTM net income for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high TTM net profit is $33.99 M
What is Ampio Pharmaceuticals TTM net income year-on-year change?
Over the past year, AMPE TTM net profit has changed by +$7.71 M (+47.16%)